U.S. Neuropathic Pain Market Size & Outlook, 2026-2033
Related Markets
U.S. neuropathic pain market highlights
- The U.S. neuropathic pain market generated a revenue of USD 2,853.9 million in 2025 and is expected to reach USD 4,568.5 million by 2033.
- The U.S. market is expected to grow at a CAGR of 6.1% from 2026 to 2033.
- In terms of segment, anticonvulsants was the largest revenue generating drug type in 2025.
- Topical Agents is the most lucrative drug type segment registering the fastest growth during the forecast period.
Neuropathic pain market data book summary
| Market revenue in 2025 | USD 2,853.9 million |
| Market revenue in 2033 | USD 4,568.5 million |
| Growth rate | 6.1% (CAGR from 2026 to 2033) |
| Largest segment | Anticonvulsants |
| Fastest growing segment | Topical Agents |
| Historical data | 2021 - 2024 |
| Base year | 2025 |
| Forecast period | 2026 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Anticonvulsants, Antidepressants, Opioids, Topical Agents |
| Key market players worldwide | Pfizer Inc, Eli Lilly and Co, Johnson & Johnson, Novartis AG ADR, Viatris Inc, Teva Pharmaceutical Industries Ltd, AbbVie Inc, Grunenthal Pharma, Vertex Pharmaceuticals Inc, Daiichi Sankyo Co Ltd |
Other key industry trends
- In terms of revenue, U.S. accounted for 33.5% of the global neuropathic pain market in 2025.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2033.
- In North America, U.S. neuropathic pain market is projected to lead the regional market in terms of revenue in 2033.
- Canada is the fastest growing regional market in North America and is projected to reach USD 500.8 million by 2033.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Neuropathic Pain Market Scope
Neuropathic Pain Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Grunenthal Pharma | View profile | 101-250 | Humanes De Madrid, Madrid, Spain, Europe | https://www.grunenthal.es/ |
| Daiichi Sankyo Co Ltd | View profile | 17435 | 3-5-1, Nihonbashi-honcho, Chuo-ku, Tokyo, Japan, 103-8426 | https://www.daiichisankyo.com |
| Vertex Pharmaceuticals Inc | View profile | 5400 | 50 Northern Avenue, Boston, MA, United States, 02210 | https://www.vrtx.com |
| Viatris Inc | View profile | 38000 | 1000 Mylan Boulevard, Canonsburg, PA, United States, 15317 | https://www.viatris.com |
| Eli Lilly and Co | View profile | 43000 | Lilly Corporate Center, Indianapolis, IN, United States, 46285 | https://www.lilly.com |
| Pfizer Inc | View profile | 88000 | 66 Hudson Boulevard East, New York, NY, United States, 10001-2192 | https://www.pfizer.com |
| AbbVie Inc | View profile | 50000 | 1 North Waukegan Road, North Chicago, IL, United States, 60064-6400 | http://www.abbvieinvestor.com |
| Teva Pharmaceutical Industries Ltd | View profile | 37851 | 124 Dvora HaNevi’a Street, Tel Aviv, Israel, 6944020 | https://www.tevapharm.com |
| Novartis AG ADR | View profile | 76057 | Lichtstrasse 35, Basel, Switzerland, 4056 | https://www.novartis.com |
| Johnson & Johnson | View profile | 134400 | One Johnson and Johnson Plaza, New Brunswick, NJ, United States, 08933 | https://www.jnj.com |
U.S. neuropathic pain market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to neuropathic pain market will help companies and investors design strategic landscapes.
Anticonvulsants was the largest segment with a revenue share of 42.34% in 2025. Horizon Databook has segmented the U.S. neuropathic pain market based on anticonvulsants, antidepressants, opioids, topical agents covering the revenue growth of each sub-segment from 2021 to 2033.
Reasons to subscribe to U.S. neuropathic pain market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of U.S. neuropathic pain market databook
-
Our clientele includes a mix of neuropathic pain market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the U.S. neuropathic pain market , including forecasts for subscribers. This country databook contains high-level insights into U.S. neuropathic pain market from 2021 to 2033, including revenue numbers, major trends, and company profiles.
Partial client list
U.S. neuropathic pain market size, by drug type, 2021-2033 (US$M)
U.S. Neuropathic Pain Market Outlook Share, 2025 & 2033 (US$M)
Related industry reports
Related statistics
No records
No related statistics found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
